| 10th Nov 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Nov 2022 9:00 am |
RNS |
Block Listing Application |
| 8th Nov 2022 9:26 am |
RNS |
Launch of Tender Offer for outstanding Notes |
| 7th Nov 2022 7:00 am |
RNS |
DREAMM-3 phase III trial for Blenrep |
| 3rd Nov 2022 1:00 pm |
RNS |
Publication of Suppl.Prospcts |
| 3rd Nov 2022 7:00 am |
RNS |
IDMC recommends gepotidacin early efficacy stop |
| 2nd Nov 2022 7:01 am |
RNS |
3rd Quarter Results |
| 2nd Nov 2022 7:00 am |
RNS |
GSK RSV vaccine: US FDA Priority Review |
| 1st Nov 2022 3:00 pm |
RNS |
Total Voting Rights |
| 28th Oct 2022 7:00 am |
RNS |
EMA validates MAA for cabotegravir LA for PrEP |
| 28th Oct 2022 7:00 am |
RNS |
EMA accepts GSK RSV older adult vaccine for review |
| 27th Oct 2022 7:05 am |
RNS |
GSK announces FDA meeting outcome on daprodustat |
| 27th Oct 2022 7:00 am |
RNS |
ContRAst phase III programme for otilimab update |
| 25th Oct 2022 10:00 am |
RNS |
Board Committee Changes |
| 21st Oct 2022 7:00 am |
RNS |
RSV older adult vaccine submission in Japan |
| 17th Oct 2022 7:00 am |
RNS |
Menveo new single-vial approve by US FDA |
| 17th Oct 2022 7:00 am |
RNS |
Menveo new single-vial approved by US FDA |
| 14th Oct 2022 2:11 pm |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2022 12:46 pm |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2022 9:44 am |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2022 8:26 am |
RNS |
Director/PDMR Shareholding |
| 13th Oct 2022 7:00 am |
RNS |
Efficacy results for GSK’s older adult RSV vaccine |
| 12th Oct 2022 11:42 am |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2022 7:00 am |
RNS |
US FDA approves Boostrix maternal immunisation |
| 7th Oct 2022 4:38 pm |
RNS |
Director/PDMR Shareholding |
| 7th Oct 2022 4:24 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Oct 2022 10:10 am |
RNS |
Total Voting Rights |
| 30th Sep 2022 5:21 pm |
RNS |
Director/PDMR Shareholding |
| 26th Sep 2022 5:09 pm |
RNS |
Director/PDMR Shareholding |
| 26th Sep 2022 7:00 am |
RNS |
GSK Chief Financial Officer succession |
| 22nd Sep 2022 2:00 pm |
RNS |
US FDA ODAC review of Zejula Phase III NOVA trial |
| 22nd Sep 2022 7:00 am |
RNS |
GSK and Spero Therapeutics licence for tebipenem |
| 21st Sep 2022 11:22 am |
RNS |
Director/PDMR Shareholding |
| 13th Sep 2022 9:11 am |
RNS |
Director/PDMR Shareholding |
| 9th Sep 2022 9:11 am |
RNS |
Publication of Base Prospectus |
| 8th Sep 2022 12:58 pm |
RNS |
Director/PDMR Shareholding |
| 6th Sep 2022 1:00 pm |
RNS |
GSK provides update on FDA review of daprodustat |
| 1st Sep 2022 11:48 am |
RNS |
Total Voting Rights |
| 24th Aug 2022 7:00 am |
RNS |
GSK Board changes |
| 22nd Aug 2022 4:53 pm |
RNS |
Director/PDMR Shareholding |
